16 results on '"Ushio, Noritaka"'
Search Results
2. Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: An observational study
- Author
-
Ushio, Noritaka, Yamakawa, Kazuma, Mochizuki, Katsunori, Hisamune, Ryo, Umemura, Yutaka, and Takasu, Akira
- Published
- 2024
- Full Text
- View/download PDF
3. The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma
- Author
-
Hayakawa, Mineji, Tagami, Takashi, Kudo, Daisuke, Ono, Kota, Aoki, Makoto, Endo, Akira, Yumoto, Tetsuya, Matsumura, Yosuke, Irino, Shiho, Sekine, Kazuhiko, Ushio, Noritaka, Ogura, Takayuki, Nachi, Sho, Irie, Yuhei, Hayakawa, Katsura, Ito, Yusuke, Okishio, Yuko, Muronoi, Tomohiro, Kosaki, Yoshinori, Ito, Kaori, Nakatsutsumi, Keita, Kondo, Yutaka, Ueda, Taichiro, Fukuma, Hiroshi, Saisaka, Yuichi, Tominaga, Naoki, Kurita, Takeo, Nakayama, Fumihiko, Shibata, Tomotaka, and Kushimoto, Shigeki
- Published
- 2023
- Full Text
- View/download PDF
4. Anticoagulant therapy for sepsis-associated DIC
- Author
-
USHIO, Noritaka, primary and YAMAKAWA, Kazuma, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Association of trauma severity with antibody seroconversion in heparin-induced thrombocytopenia: A multicenter, prospective, observational study
- Author
-
Fujita, Motoo, Maeda, Takuma, Miyata, Shigeki, Mizugaki, Asumi, Hayakawa, Mineji, Miyagawa, Noriko, Ushio, Noritaka, Shiraishi, Atsushi, Ogura, Takayuki, Irino, Shiho, Sekine, Kazuhiko, Fujinami, Yoshihisa, Kiridume, Kazutaka, Hifumi, Toru, and Kushimoto, Shigeki
- Published
- 2022
- Full Text
- View/download PDF
6. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)
- Author
-
Egi, Moritoki, Ogura, Hiroshi, Yatabe, Tomoaki, Atagi, Kazuaki, Inoue, Shigeaki, Iba, Toshiaki, Kakihana, Yasuyuki, Kawasaki, Tatsuya, Kushimoto, Shigeki, Kuroda, Yasuhiro, Kotani, Joji, Shime, Nobuaki, Taniguchi, Takumi, Tsuruta, Ryosuke, Doi, Kent, Doi, Matsuyuki, Nakada, Taka-aki, Nakane, Masaki, Fujishima, Seitaro, Hosokawa, Naoto, Masuda, Yoshiki, Matsushima, Asako, Matsuda, Naoyuki, Yamakawa, Kazuma, Hara, Yoshitaka, Sakuraya, Masaaki, Ohshimo, Shinichiro, Aoki, Yoshitaka, Inada, Mai, Umemura, Yutaka, Kawai, Yusuke, Kondo, Yutaka, Saito, Hiroki, Taito, Shunsuke, Takeda, Chikashi, Terayama, Takero, Tohira, Hideo, Hashimoto, Hideki, Hayashida, Kei, Hifumi, Toru, Hirose, Tomoya, Fukuda, Tatsuma, Fujii, Tomoko, Miura, Shinya, Yasuda, Hideto, Abe, Toshikazu, Andoh, Kohkichi, Iida, Yuki, Ishihara, Tadashi, Ide, Kentaro, Ito, Kenta, Ito, Yusuke, Inata, Yu, Utsunomiya, Akemi, Unoki, Takeshi, Endo, Koji, Ouchi, Akira, Ozaki, Masayuki, Ono, Satoshi, Katsura, Morihiro, Kawaguchi, Atsushi, Kawamura, Yusuke, Kudo, Daisuke, Kubo, Kenji, Kurahashi, Kiyoyasu, Sakuramoto, Hideaki, Shimoyama, Akira, Suzuki, Takeshi, Sekine, Shusuke, Sekino, Motohiro, Takahashi, Nozomi, Takahashi, Sei, Takahashi, Hiroshi, Tagami, Takashi, Tajima, Goro, Tatsumi, Hiroomi, Tani, Masanori, Tsuchiya, Asuka, Tsutsumi, Yusuke, Naito, Takaki, Nagae, Masaharu, Nagasawa, Ichiro, Nakamura, Kensuke, Nishimura, Tetsuro, Nunomiya, Shin, Norisue, Yasuhiro, Hashimoto, Satoru, Hasegawa, Daisuke, Hatakeyama, Junji, Hara, Naoki, Higashibeppu, Naoki, Furushima, Nana, Furusono, Hirotaka, Matsuishi, Yujiro, Matsuyama, Tasuku, Minematsu, Yusuke, Miyashita, Ryoichi, Miyatake, Yuji, Moriyasu, Megumi, Yamada, Toru, Yamada, Hiroyuki, Yamamoto, Ryo, Yoshida, Takeshi, Yoshida, Yuhei, Yoshimura, Jumpei, Yotsumoto, Ryuichi, Yonekura, Hiroshi, Wada, Takeshi, Watanabe, Eizo, Aoki, Makoto, Asai, Hideki, Abe, Takakuni, Igarashi, Yutaka, Iguchi, Naoya, Ishikawa, Masami, Ishimaru, Go, Isokawa, Shutaro, Itakura, Ryuta, Imahase, Hisashi, Imura, Haruki, Irinoda, Takashi, Uehara, Kenji, Ushio, Noritaka, Umegaki, Takeshi, Egawa, Yuko, Enomoto, Yuki, Ota, Kohei, Ohchi, Yoshifumi, Ohno, Takanori, Ohbe, Hiroyuki, Oka, Kazuyuki, Okada, Nobunaga, Okada, Yohei, Okano, Hiromu, Okamoto, Jun, Okuda, Hiroshi, Ogura, Takayuki, Onodera, Yu, Oyama, Yuhta, Kainuma, Motoshi, Kako, Eisuke, Kashiura, Masahiro, Kato, Hiromi, Kanaya, Akihiro, Kaneko, Tadashi, Kanehata, Keita, Kano, Ken-ichi, Kawano, Hiroyuki, Kikutani, Kazuya, Kikuchi, Hitoshi, Kido, Takahiro, Kimura, Sho, Koami, Hiroyuki, Kobashi, Daisuke, Saiki, Iwao, Sakai, Masahito, Sakamoto, Ayaka, Sato, Tetsuya, Shiga, Yasuhiro, Shimoto, Manabu, Shimoyama, Shinya, Shoko, Tomohisa, Sugawara, Yoh, Sugita, Atsunori, Suzuki, Satoshi, Suzuki, Yuji, Suhara, Tomohiro, Sonota, Kenji, Takauji, Shuhei, Takashima, Kohei, Takahashi, Sho, Takahashi, Yoko, Takeshita, Jun, Tanaka, Yuuki, Tampo, Akihito, Tsunoyama, Taichiro, Tetsuhara, Kenichi, Tokunaga, Kentaro, Tomioka, Yoshihiro, Tomita, Kentaro, Tominaga, Naoki, Toyosaki, Mitsunobu, Toyoda, Yukitoshi, Naito, Hiromichi, Nagata, Isao, Nagato, Tadashi, Nakamura, Yoshimi, Nakamori, Yuki, Nahara, Isao, Naraba, Hiromu, Narita, Chihiro, Nishioka, Norihiro, Nishimura, Tomoya, Nishiyama, Kei, Nomura, Tomohisa, Haga, Taiki, Hagiwara, Yoshihiro, Hashimoto, Katsuhiko, Hatachi, Takeshi, Hamasaki, Toshiaki, Hayashi, Takuya, Hayashi, Minoru, Hayamizu, Atsuki, Haraguchi, Go, Hirano, Yohei, Fujii, Ryo, Fujita, Motoki, Fujimura, Naoyuki, Funakoshi, Hiraku, Horiguchi, Masahito, Maki, Jun, Masunaga, Naohisa, Matsumura, Yosuke, Mayumi, Takuya, Minami, Keisuke, Miyazaki, Yuya, Miyamoto, Kazuyuki, Murata, Teppei, Yanai, Machi, Yano, Takao, Yamada, Kohei, Yamada, Naoki, Yamamoto, Tomonori, Yoshihiro, Shodai, Tanaka, Hiroshi, and Nishida, Osamu
- Published
- 2021
- Full Text
- View/download PDF
7. Early restricted oxygen therapy after resuscitation from cardiac arrest (ER-OXYTRAC): protocol for a stepped-wedge cluster randomised controlled trial
- Author
-
Yamamoto, Ryo, primary, Yamakawa, Kazuma, additional, Endo, Akira, additional, Homma, Koichiro, additional, Sato, Yasunori, additional, Takemura, Ryo, additional, Yamagiwa, Takeshi, additional, Shimizu, Keiki, additional, Kaito, Daiki, additional, Yagi, Masayuki, additional, Yonemura, Taku, additional, Shibusawa, Takayuki, additional, Suzuki, Ginga, additional, Shoji, Takahiro, additional, Miura, Naoya, additional, Takahashi, Jiro, additional, Narita, Chihiro, additional, Kurata, Saori, additional, Minami, Kazunobu, additional, Wada, Takeshi, additional, Fujinami, Yoshihisa, additional, Tsubouchi, Yohei, additional, Natsukawa, Mai, additional, Nagayama, Jun, additional, Takayama, Wataru, additional, Ishikura, Ken, additional, Yokokawa, Kyoko, additional, Fujita, Yasuo, additional, Nakayama, Hirofumi, additional, Tokuyama, Hideki, additional, Shinada, Kota, additional, Taira, Takayuki, additional, Fukui, Shoki, additional, Ushio, Noritaka, additional, Nakane, Masaki, additional, Hoshiyama, Eisei, additional, Tampo, Akihito, additional, Sageshima, Hisako, additional, Takami, Hiroki, additional, Iizuka, Shinichi, additional, Kikuchi, Hitoshi, additional, Hagiwara, Jun, additional, Tagami, Takashi, additional, Funato, Yumi, additional, Sasaki, Junichi, additional, and ER-OXYTRAC, study group, additional
- Published
- 2023
- Full Text
- View/download PDF
8. Effect of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single center retrospective study
- Author
-
Takahashi, Yoshihiko, primary, Utsumi, Shu, additional, Fujizuka, Kenji, additional, Suzuki, Hiroyuki, additional, Ushio, Noritaka, additional, Amemiya, Yu, additional, and Nakamura, Mitsunobu, additional
- Published
- 2023
- Full Text
- View/download PDF
9. Sepsis‐induced disseminated intravascular coagulation: an international estrangement of disease concept
- Author
-
Ushio, Noritaka, primary, Wada, Takeshi, additional, Ono, Yuichiro, additional, and Yamakawa, Kazuma, additional
- Published
- 2023
- Full Text
- View/download PDF
10. Clinical efficacy of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single-center retrospective study
- Author
-
Takahashi, Yoshihiko, primary, Utsumi, Shu, additional, Fujizuka, Kenji, additional, Suzuki, Hiroyuki, additional, Ushio, Noritaka, additional, Amemiya, Yu, additional, and Nakamura, Mitsunobu, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Association of Trauma Severity with Antibody Seroconversion in Heparin-Induced Thrombocytopenia: A Multicenter, Prospective Observational Study
- Author
-
Fujita, Motoo, primary, Maeda, Takuma, additional, Miyata, Shigeki, additional, Mizugaki, Asumi, additional, Hayakawa, Mineji, additional, Miyagawa, Noriko, additional, Ushio, Noritaka, additional, Shiraishi, Atsushi, additional, Ogura, Takayuki, additional, Irino, Shiho, additional, Sekine, Kazuhiko, additional, Fujinami, Yoshihisa, additional, Kiridume, Kazutaka, additional, Hifumi, Toru, additional, and Kushimoto, Shigeki, additional
- Published
- 2021
- Full Text
- View/download PDF
12. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)
- Author
-
Egi, Moritoki, primary, Ogura, Hiroshi, additional, Yatabe, Tomoaki, additional, Atagi, Kazuaki, additional, Inoue, Shigeaki, additional, Iba, Toshiaki, additional, Kakihana, Yasuyuki, additional, Kawasaki, Tatsuya, additional, Kushimoto, Shigeki, additional, Kuroda, Yasuhiro, additional, Kotani, Joji, additional, Shime, Nobuaki, additional, Taniguchi, Takumi, additional, Tsuruta, Ryosuke, additional, Doi, Kent, additional, Doi, Matsuyuki, additional, Nakada, Taka‐aki, additional, Nakane, Masaki, additional, Fujishima, Seitaro, additional, Hosokawa, Naoto, additional, Masuda, Yoshiki, additional, Matsushima, Asako, additional, Matsuda, Naoyuki, additional, Yamakawa, Kazuma, additional, Hara, Yoshitaka, additional, Sakuraya, Masaaki, additional, Ohshimo, Shinichiro, additional, Aoki, Yoshitaka, additional, Inada, Mai, additional, Umemura, Yutaka, additional, Kawai, Yusuke, additional, Kondo, Yutaka, additional, Saito, Hiroki, additional, Taito, Shunsuke, additional, Takeda, Chikashi, additional, Terayama, Takero, additional, Tohira, Hideo, additional, Hashimoto, Hideki, additional, Hayashida, Kei, additional, Hifumi, Toru, additional, Hirose, Tomoya, additional, Fukuda, Tatsuma, additional, Fujii, Tomoko, additional, Miura, Shinya, additional, Yasuda, Hideto, additional, Abe, Toshikazu, additional, Andoh, Kohkichi, additional, Iida, Yuki, additional, Ishihara, Tadashi, additional, Ide, Kentaro, additional, Ito, Kenta, additional, Ito, Yusuke, additional, Inata, Yu, additional, Utsunomiya, Akemi, additional, Unoki, Takeshi, additional, Endo, Koji, additional, Ouchi, Akira, additional, Ozaki, Masayuki, additional, Ono, Satoshi, additional, Katsura, Morihiro, additional, Kawaguchi, Atsushi, additional, Kawamura, Yusuke, additional, Kudo, Daisuke, additional, Kubo, Kenji, additional, Kurahashi, Kiyoyasu, additional, Sakuramoto, Hideaki, additional, Shimoyama, Akira, additional, Suzuki, Takeshi, additional, Sekine, Shusuke, additional, Sekino, Motohiro, additional, Takahashi, Nozomi, additional, Takahashi, Sei, additional, Takahashi, Hiroshi, additional, Tagami, Takashi, additional, Tajima, Goro, additional, Tatsumi, Hiroomi, additional, Tani, Masanori, additional, Tsuchiya, Asuka, additional, Tsutsumi, Yusuke, additional, Naito, Takaki, additional, Nagae, Masaharu, additional, Nagasawa, Ichiro, additional, Nakamura, Kensuke, additional, Nishimura, Tetsuro, additional, Nunomiya, Shin, additional, Norisue, Yasuhiro, additional, Hashimoto, Satoru, additional, Hasegawa, Daisuke, additional, Hatakeyama, Junji, additional, Hara, Naoki, additional, Higashibeppu, Naoki, additional, Furushima, Nana, additional, Furusono, Hirotaka, additional, Matsuishi, Yujiro, additional, Matsuyama, Tasuku, additional, Minematsu, Yusuke, additional, Miyashita, Ryoichi, additional, Miyatake, Yuji, additional, Moriyasu, Megumi, additional, Yamada, Toru, additional, Yamada, Hiroyuki, additional, Yamamoto, Ryo, additional, Yoshida, Takeshi, additional, Yoshida, Yuhei, additional, Yoshimura, Jumpei, additional, Yotsumoto, Ryuichi, additional, Yonekura, Hiroshi, additional, Wada, Takeshi, additional, Watanabe, Eizo, additional, Aoki, Makoto, additional, Asai, Hideki, additional, Abe, Takakuni, additional, Igarashi, Yutaka, additional, Iguchi, Naoya, additional, Ishikawa, Masami, additional, Ishimaru, Go, additional, Isokawa, Shutaro, additional, Itakura, Ryuta, additional, Imahase, Hisashi, additional, Imura, Haruki, additional, Irinoda, Takashi, additional, Uehara, Kenji, additional, Ushio, Noritaka, additional, Umegaki, Takeshi, additional, Egawa, Yuko, additional, Enomoto, Yuki, additional, Ota, Kohei, additional, Ohchi, Yoshifumi, additional, Ohno, Takanori, additional, Ohbe, Hiroyuki, additional, Oka, Kazuyuki, additional, Okada, Nobunaga, additional, Okada, Yohei, additional, Okano, Hiromu, additional, Okamoto, Jun, additional, Okuda, Hiroshi, additional, Ogura, Takayuki, additional, Onodera, Yu, additional, Oyama, Yuhta, additional, Kainuma, Motoshi, additional, Kako, Eisuke, additional, Kashiura, Masahiro, additional, Kato, Hiromi, additional, Kanaya, Akihiro, additional, Kaneko, Tadashi, additional, Kanehata, Keita, additional, Kano, Ken‐ichi, additional, Kawano, Hiroyuki, additional, Kikutani, Kazuya, additional, Kikuchi, Hitoshi, additional, Kido, Takahiro, additional, Kimura, Sho, additional, Koami, Hiroyuki, additional, Kobashi, Daisuke, additional, Saiki, Iwao, additional, Sakai, Masahito, additional, Sakamoto, Ayaka, additional, Sato, Tetsuya, additional, Shiga, Yasuhiro, additional, Shimoto, Manabu, additional, Shimoyama, Shinya, additional, Shoko, Tomohisa, additional, Sugawara, Yoh, additional, Sugita, Atsunori, additional, Suzuki, Satoshi, additional, Suzuki, Yuji, additional, Suhara, Tomohiro, additional, Sonota, Kenji, additional, Takauji, Shuhei, additional, Takashima, Kohei, additional, Takahashi, Sho, additional, Takahashi, Yoko, additional, Takeshita, Jun, additional, Tanaka, Yuuki, additional, Tampo, Akihito, additional, Tsunoyama, Taichiro, additional, Tetsuhara, Kenichi, additional, Tokunaga, Kentaro, additional, Tomioka, Yoshihiro, additional, Tomita, Kentaro, additional, Tominaga, Naoki, additional, Toyosaki, Mitsunobu, additional, Toyoda, Yukitoshi, additional, Naito, Hiromichi, additional, Nagata, Isao, additional, Nagato, Tadashi, additional, Nakamura, Yoshimi, additional, Nakamori, Yuki, additional, Nahara, Isao, additional, Naraba, Hiromu, additional, Narita, Chihiro, additional, Nishioka, Norihiro, additional, Nishimura, Tomoya, additional, Nishiyama, Kei, additional, Nomura, Tomohisa, additional, Haga, Taiki, additional, Hagiwara, Yoshihiro, additional, Hashimoto, Katsuhiko, additional, Hatachi, Takeshi, additional, Hamasaki, Toshiaki, additional, Hayashi, Takuya, additional, Hayashi, Minoru, additional, Hayamizu, Atsuki, additional, Haraguchi, Go, additional, Hirano, Yohei, additional, Fujii, Ryo, additional, Fujita, Motoki, additional, Fujimura, Naoyuki, additional, Funakoshi, Hiraku, additional, Horiguchi, Masahito, additional, Maki, Jun, additional, Masunaga, Naohisa, additional, Matsumura, Yosuke, additional, Mayumi, Takuya, additional, Minami, Keisuke, additional, Miyazaki, Yuya, additional, Miyamoto, Kazuyuki, additional, Murata, Teppei, additional, Yanai, Machi, additional, Yano, Takao, additional, Yamada, Kohei, additional, Yamada, Naoki, additional, Yamamoto, Tomonori, additional, Yoshihiro, Shodai, additional, Tanaka, Hiroshi, additional, and Nishida, Osamu, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Phenotypic changes in immune cells induced by granulocyte and monocyte adsorptive apheresis in patients with severe COVID-19: An ex vivo study.
- Author
-
Hisamune R, Yamakawa K, Kayano K, Ushio N, Wada T, Taniguchi K, and Takasu A
- Abstract
Aims: SARS-CoV-2 causes systemic immune dysfunction, leading to severe respiratory dysfunction and multiorgan dysfunction. Granulocyte and monocyte adsorptive apheresis (GMA) therapy is designed to regulate an excessive inflammatory response and has been proposed as a potential therapeutic strategy for coronavirus disease 2019 (COVID-19). We aimed to investigate a targeted subset of granulocytes and monocytes to be removed after GMA therapy in patients with severe COVID-19 infection., Methods: We established an ex vivo experimental system to study the effects of GMA. Blood samples were collected into EDTA-treated tubes and a mixture of blood samples and cellulose acetate beads was used in GMA. After GMA, blood samples were removed, and the granulocyte and monocyte subtypes before and after GMA were determined by CyTOF mass cytometry. To analyze mass cytometry data with a self-organizing map, hierarchical clustering was used to determine the appropriate number of metaclusters from t-distributed stochastic neighbor embedding., Results: We included seven patients with severe COVID-19 and four age- and sex-matched volunteers. Granulocyte subsets removed by GMA strongly expressed CD11b, CD16, and CD66b, and weakly expressed CD11c, consistent with mature and activated neutrophils. Monocyte subsets strongly expressed CD14, weakly expressed CD33 and CD45RO, and did not express CD16. These subsets were indicated to promote the release of inflammatory cytokines and activate T cells., Conclusions: The identification of the granulocyte and monocyte subsets removed after GMA in patients with severe COVID-19 may help explain the potential mechanism underlying the effectiveness of GMA in COVID-19 and other inflammatory diseases., Competing Interests: KY reported receiving grants from JIMRO Co. Ltd. No other disclosures are reported. AT is an Editorial Board Member of AMS Journal and a co‐author of this article. To minimize bias, they were excluded from all editorial decision‐making related to the acceptance of this article for publication., (© 2024 The Author(s). Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
14. Association Between IV Contrast Media Exposure and Acute Kidney Injury in Patients Requiring Emergency Admission: A Nationwide Observational Study in Japan.
- Author
-
Hisamune R, Yamakawa K, Umemura Y, Ushio N, Mochizuki K, Inokuchi R, Doi K, and Takasu A
- Subjects
- Humans, Japan epidemiology, Male, Female, Aged, Retrospective Studies, Middle Aged, Aged, 80 and over, Propensity Score, Tomography, X-Ray Computed, Renal Replacement Therapy, Risk Factors, Acute Kidney Injury chemically induced, Acute Kidney Injury mortality, Acute Kidney Injury epidemiology, Acute Kidney Injury therapy, Contrast Media adverse effects, Contrast Media administration & dosage, Hospital Mortality
- Abstract
Objective: This study aimed to elucidate the association between IV contrast media CT and acute kidney injury (AKI) and in-hospital mortality among patients requiring emergency admission., Design: In this retrospective observational study, we examined AKI within 48 hours after CT, renal replacement therapy (RRT) dependence at discharge, and in-hospital mortality in patients undergoing contrast-enhanced CT or nonenhanced CT. We performed 1:1 propensity score matching to adjust for confounders in the association between IV contrast media use and outcomes. Subgroup analyses were performed according to age, sex, diagnosis at admission, ICU admission, and preexisting chronic kidney disease (CKD)., Setting and Patients: This study used the Medical Data Vision database between 2008 and 2019. This database is Japan's largest commercially available hospital-based claims database, covering about 45% of acute-care hospitals in Japan, and it also records laboratory results., Interventions: None., Measurements and Main Results: The study included 144,149 patients with (49,057) and without (95,092) contrast media exposure, from which 43,367 propensity score-matched pairs were generated. Between the propensity score-matched groups of overall patients, exposure to contrast media showed no significant risk of AKI (4.6% vs. 5.1%; odds ratio [OR], 0.899; 95% CI, 0.845-0.958) or significant risk of RRT dependence (0.6% vs. 0.4%; OR, 1.297; 95% CI, 1.070-1.574) and significant benefit for in-hospital mortality (5.4% vs. 6.5%; OR, 0.821; 95% CI, 0.775-0.869). In subgroup analyses regarding preexisting CKD, exposure to contrast media was a significant risk for AKI in patients with CKD but not in those without CKD., Conclusions: In this large-scale observational study, IV contrast media was not associated with an increased risk of AKI but concurrently showed beneficial effects on in-hospital mortality among patients requiring emergency admission., Competing Interests: The authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
15. Efficacy of antithrombin administration for patients with sepsis: A systematic review, meta-analysis, and meta-regression.
- Author
-
Tsuchida T, Makino Y, Wada T, Ushio N, Totoki T, Fujie N, Yasuo S, Matsuoka T, Koami H, Yamakawa K, and Iba T
- Abstract
Aims: There have been inconsistent reports regarding the effect of antithrombin on sepsis; furthermore, there are limited reports on how dosage affects therapeutic efficacy. Thus, we aimed to perform a systematic review and meta-analysis of the use of antithrombin for sepsis and a meta-regression analysis of antithrombin dosage., Methods: We included randomized controlled trials (RCTs) and observational studies of adult patients with sepsis who received antithrombin. Outcomes included all-cause mortality and serious bleeding complications. Statistical analyses and data synthesis were performed using a random-effects model; further, meta-regression and funnel plots were used to explore heterogeneity and biases., Results: Seven RCTs and six observational studies were included. Most patients in the RCTs and observational studies had severe sepsis and septic-disseminated intravascular coagulation (DIC), respectively. A meta-analysis using RCTs showed no significant differences in mortality between the antithrombin and control groups. However, the meta-analysis of observational studies indicated a trend of decreasing mortality rates with antithrombin administration (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.68-0.92; p = 0.002). Bleeding complications were significantly higher in the antithrombin group than in the control group in both study types (OR, 1.90; 95% CI, 1.52-2.37; p < 0.01). The meta-regression analysis showed no correlation between antithrombin dosage and mortality., Conclusion: A meta-analysis of RCTs confirmed no survival benefit of antithrombin, whereas that of observational studies, which mostly focused on septic DIC, showed a significant beneficial effect on improving outcomes. Indications of antithrombin should be considered based on its beneficial and harmful effects., Competing Interests: T.W. received honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Asahi Kasei Pharma and Japan Blood Products Organization. K.Y. reported receiving a research grant from Japan Blood Products Organization. T.I received a grant from JIMRO, a consulting fee from Japan Blood Products Organization, and honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Asahi Kasei Pharma and Toray Medical. The other authors declare no conflict of interests for this article. T.I. is an Editorial Board member of AMS Journal and a co‐author of this article. To minimize bias, they were excluded from all editorial decision‐making related to the acceptance of this article for publication., (© 2024 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
16. Current Clinical Practice of Laboratory Testing of the Hemostasis and Coagulation System in Patients with Sepsis: A Nationwide Observational Study in Japan.
- Author
-
Yamakawa K, Ohbe H, Hisamune R, Ushio N, Matsui H, Fushimi K, and Yasunaga H
- Abstract
Introduction: The clinical benefit of hemostasis molecular indicators such as thrombin-antithrombin complex (TAT), soluble fibrin (SF), and prothrombin fragment 1 + 2 (F1+2) for the diagnosis of disseminated intravascular coagulation (DIC) is reported. Recently, novel DIC diagnostic criteria that adopt them were proposed in Japan. Despite the theoretical understanding of their function, the practical use of these markers remains unclear. The present study aimed to provide a descriptive overview of current clinical practice regarding the measurement of hemostasis markers in sepsis management in Japan., Methods: This retrospective observational analysis used the Japanese Diagnosis Procedure Combination inpatient database containing data from more than 1500 acute-care hospitals in Japan. We identified adult patients hospitalized for sepsis between April 2018 and March 2021. Descriptive statistics for measuring several hemostasis laboratory markers were summarized using patient disease characteristics, hospital characteristic, and geographical location., Results: This study included 153,474 adult sepsis patients. Crude in-hospital mortality was 30.0%. Frequency of measurement of fibrinogen, fibrin degradation products (FDP), and D-dimer in sepsis patients on admission was 43.2%, 36.1%, and 46.4%, respectively. Novel and specific hemostasis molecular markers such as TAT, SF, and F1+2 were seldom measured (1.9%, 1.7%, and 0.02%, respectively). Hemostasis molecular markers were more frequently measured with progression of thrombocytopenia. Measurement of these clinically favorite hemostasis markers was influenced not only by disease characteristics but also hospital characteristic or geographical location., Conclusions: Hemostasis molecular markers such as TAT, SF, and F1+2 were rarely measured in clinical settings. Although adopted by several DIC scoring systems, neither fibrinogen, FDP, nor D-dimer was routinely measured., Competing Interests: Kazuma Yamakawa received research grants from Asahi Kasei Pharma and the Japan Blood Products Organization., (Copyright © Japan Medical Association.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.